Role of the blood-cerebrospinal fluid barrier transporter as a cerebral clearance system for prostaglandin E2 produced in the brain

Journal of Neurochemistry

Volumn 123, Issue 5, 2012, Pages 750-760

  Tachikawa, Masanori ^a,b   Ozeki, Go ^a   Higuchi, Takanori ^a   Akanuma, Shin Ichi ^a   Tsuji, Kazuhiro ^a   Hosoya, Ken Ichi ^a  

^a UNIVERSITY OF TOYAMA   (Japan)

^b TOHOKU UNIVERSITY   (Japan)

Author keywords

blood cerebrospinal fluid barrier; clearance; inflammation; mPGES 1; prostaglandin E2; prostaglandin synthase

Indexed keywords

ORGANIC ANION TRANSPORTER 3; PROSTAGLANDIN E SYNTHASE 1; PROSTAGLANDIN E2;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD CEREBROSPINAL FLUID BARRIER; CONTROLLED STUDY; ENZYME LOCALIZATION; FEMALE; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; MALE; MICHAELIS CONSTANT; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROSTAGLANDIN METABOLISM; PROSTAGLANDIN SYNTHESIS; PROTEIN EXPRESSION; RAT; REGULATORY MECHANISM;

ANIMALS; BLOOD-BRAIN BARRIER; BRAIN; CHOROID PLEXUS; DINOPROSTONE; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; INTRAMOLECULAR OXIDOREDUCTASES; MALE; MICE; ORGANIC ANION TRANSPORTERS, SODIUM-INDEPENDENT; RATS; XENOPUS LAEVIS;

BACTERIA (MICROORGANISMS);

EID: 84868661468     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/jnc.12018     Document Type: Article

References (60)

1. Adachi H., Suzuki T., Abe M., et al,. (2003) Molecular characterization of human and rat organic anion transporter OATP-D. Am. J. Physiol. Renal Physiol. 285, F1188-F1197.
2. Akanuma S., Hosoya K., Ito S., Tachikawa M., Terasaki T., and, Ohtsuki S., (2010) Involvement of multidrug resistance-associated protein 4 in efflux transport of prostaglandin E(2) across mouse blood-brain barrier and its inhibition by intravenous administration of cephalosporins. J. Pharmacol. Exp. Ther. 333, 912-919.
3. Alix E., Schmitt C., Strazielle N., and, Ghersi-Egea J. F., (2008) Prostaglandin E2 metabolism in rat brain: role of the blood-brain interfaces. Cerebrospinal Fluid Res. 5, 5.
4. Bito L. Z., Davson H., and, Hollingsworth J. R., (1976) Facilitated transport of prostaglandins across the blood-cerebrospinal fluid and blood-brain barriers. J. Physiol. 256, 273-285.
5. Carasso R. L., Vardi J., Rabay J. M., Zor U., and, Streifler M., (1977) Measurement of prostaglandin E2 in cerebrospinal fluid in patients suffering from stroke. J. Neurol. Neurosurg. Psychiatry 40, 967-969.
6. Cattori V., van Montfoort J. E., Stieger B., Landmann L., Meijer D. K., Winterhalter K. H., Meier P. J., and, Hagenbuch B., (2001) Localization of organic anion transporting polypeptide 4 (Oatp4) in rat liver and comparison of its substrate specificity with Oatp1, Oatp2 and Oatp3. Pflugers Arch. 443, 188-195.
7. Chaudhry U. A., and, Dore S., (2009) Cytosolic prostaglandin E synthase: expression patterns in control and Alzheimer's disease brains. Am. J. Alzheimers Dis. Other Demen. 24, 46-51.
8. Chaudhry U. A., Zhuang H., Crain B. J., and, Dore S., (2008) Elevated microsomal prostaglandin-E synthase-1 in Alzheimer's disease. Alzheimers Dement. 4, 6-13.
9. Chaudhry U., Zhuang H., and, Dore S., (2010) Microsomal prostaglandin E synthase-2: cellular distribution and expression in Alzheimer's disease. Exp. Neurol. 223, 359-365.
10. Craig W., (1984) Pharmacokinetic and experimental data on beta-lactam antibiotics in the treatment of patients. Eur. J. Clin. Microbiol. 3, 575-578.
11. Gao W., Schmidtko A., Wobst I., Lu R., Angioni C., and, Geisslinger G., (2009) Prostaglandin D2 produced by hematopoietic prostaglandin D synthase contributes to LPS-induced fever. J. Physiol. Pharmacol. 60, 145-150.
12. Gordon G. R., Choi H. B., Rungta R. L., Ellis-Davies G. C., and, MacVicar B. A., (2008) Brain metabolism dictates the polarity of astrocyte control over arterioles. Nature 456, 745-749.
13. Han H., Kim S. G., Lee M. G., Shim C. K., and, Chung S. J., (2002) Mechanism of the reduced elimination clearance of benzylpenicillin from cerebrospinal fluid in rats with intracisternal administration of lipopolysaccharide. Drug Metab. Dispos. 30, 1214-1220.
14. Hosoya K., Hori S., Ohtsuki S., and, Terasaki T., (2004) A new in vitro model for blood-cerebrospinal fluid barrier transport studies: an immortalized choroid plexus epithelial cell line derived from the tsA58 SV40 large T-antigen gene transgenic rat. Adv. Drug Deliv. Rev. 56, 1875-1885.
15. Ikeda-Matsuo Y., Ota A., Fukada T., Uematsu S., Akira S., and, Sasaki Y., (2006) Microsomal prostaglandin E synthase-1 is a critical factor of stroke-reperfusion injury. Proc. Natl Acad. Sci. USA 103, 11790-11795.
16. Inoue W., Matsumura K., Yamagata K., Takemiya T., Shiraki T., and, Kobayashi S., (2002) Brain-specific endothelial induction of prostaglandin E(2) synthesis enzymes and its temporal relation to fever. Neurosci. Res. 44, 51-61.
17. Jung K. Y., Takeda M., Shimoda M., et al,. (2002) Involvement of rat organic anion transporter 3 (rOAT3) in cephaloridine-induced nephrotoxicity: in comparison with rOAT1. Life Sci. 70, 1861-1874.
18. Kanai N., Lu R., Satriano J. A., Bao Y., Wolkoff A. W., and, Schuster V. L., (1995) Identification and characterization of a prostaglandin transporter. Science 268, 866-869.
19. Khuth S. T., Strazielle N., Giraudon P., Belin M. F., and, Ghersi-Egea J. F., (2005) Impairment of blood-cerebrospinal fluid barrier properties by retrovirus-activated T lymphocytes: reduction in cerebrospinal fluid-to-blood efflux of prostaglandin E2. J. Neurochem. 94, 1580-1593.
20. Kim S. Y., Chang Y. J., Cho H. M., Hwang Y. W., and, Moon Y. S., (2009) Non-steroidal anti-inflammatory drugs for the common cold. Cochrane Database Syst. Rev. CD006362.
21. Kimura H., Takeda M., Narikawa S., Enomoto A., Ichida K., and, Endou H., (2002) Human organic anion transporters and human organic cation transporters mediate renal transport of prostaglandins. J. Pharmacol. Exp. Ther. 301, 293-298.
22. Kis B., Isse T., Snipes J. A., Chen L., Yamashita H., Ueta Y., and, Busija D. W., (2006) Effects of LPS stimulation on the expression of prostaglandin carriers in the cells of the blood-brain and blood-cerebrospinal fluid barriers. J. Appl. Physiol. 100, 1392-1399.
23. Kusuhara H., He Z., Nagata Y., Nozaki Y., Ito T., Masuda H., Meier P. J., Abe T., and, Sugiyama Y., (2003) Expression and functional involvement of organic anion transporting polypeptide subtype 3 (Slc21a7) in rat choroid plexus. Pharm. Res. 20, 720-727.
24. Leggas M., Adachi M., Scheffer G. L., et al,. (2004) Mrp4 confers resistance to topotecan and protects the brain from chemotherapy. Mol. Cell. Biol. 24, 7612-7621.
25. Masuda S., Ibaramoto K., Takeuchi A., Saito H., Hashimoto Y., and, Inui K. I., (1999) Cloning and functional characterization of a new multispecific organic anion transporter, OAT-K2, in rat kidney. Mol. Pharmacol. 55, 743-752.
26. Molavi A., (1991) Cephalosporins: rationale for clinical use. Am. Fam. Physician 43, 937-948.
27. Mori S., Takanaga H., Ohtsuki S., Deguchi T., Kang Y. S., Hosoya K., and, Terasaki T., (2003) Rat organic anion transporter 3 (rOAT3) is responsible for brain-to-blood efflux of homovanillic acid at the abluminal membrane of brain capillary endothelial cells. J. Cereb. Blood Flow Metab. 23, 432-440.
28. Murakami M., Naraba H., Tanioka T., et al,. (2000) Regulation of prostaglandin E2 biosynthesis by inducible membrane-associated prostaglandin E2 synthase that acts in concert with cyclooxygenase-2. J. Biol. Chem. 275, 32783-32792.
29. Murakami M., Nakatani Y., Tanioka T., and, Kudo I., (2002) Prostaglandin E synthase. Prostaglandins Other Lipid Mediat. 68-69, 383-399.
30. Nagata Y., Kusuhara H., Endou H., and, Sugiyama Y., (2002) Expression and functional characterization of rat organic anion transporter 3 (rOat3) in the choroid plexus. Mol. Pharmacol. 61, 982-988.
31. Nakano J., Prancan A. V., and, Moore S. E., (1972) Metabolism of prostaglandin E 1 in the cerebral cortex and cerebellum of the dog and rat. Brain Res. 39, 545-548.
32. Nakashima T., Tomi M., Tachikawa M., Watanabe M., Terasaki T., and, Hosoya K., (2005) Evidence for creatine biosynthesis in Muller glia. Glia 52, 47-52.
33. Nilwarangkoon S., Anzai N., Shiraya K., et al,. (2007) Role of mouse organic anion transporter 3 (mOat3) as a basolateral prostaglandin E2 transport pathway. J. Pharmacol. Sci. 103, 48-55.
34. Ogawa M., Suzuki H., Sawada Y., Hanano M., and, Sugiyama Y., (1994) Kinetics of active efflux via choroid plexus of beta-lactam antibiotics from the CSF into the circulation. Am. J. Physiol. 266, R392-R399.
35. Ohtsuki S., Takizawa T., Takanaga H., Terasaki N., Kitazawa T., Sasaki M., Abe T., Hosoya K., and, Terasaki T., (2003) In vitro study of the functional expression of organic anion transporting polypeptide 3 at rat choroid plexus epithelial cells and its involvement in the cerebrospinal fluid-to-blood transport of estrone-3-sulfate. Mol. Pharmacol. 63, 532-537.
36. Ohtsuki S., Takizawa T., Takanaga H., Hori S., Hosoya K., and, Terasaki T., (2004) Localization of organic anion transporting polypeptide 3 (oatp3) in mouse brain parenchymal and capillary endothelial cells. J. Neurochem. 90, 743-749.
37. Reid G., Wielinga P., Zelcer N., van der Heijden I., Kuil A., de Haas M., Wijnholds J., and, Borst P., (2003) The human multidrug resistance protein MRP4 functions as a prostaglandin efflux transporter and is inhibited by nonsteroidal antiinflammatory drugs. Proc. Natl Acad. Sci. USA 100, 9244-9249.
38. Romero S. D., Chyatte D., Byer D. E., Romero J. C., and, Yaksh T. L., (1984) Measurement of prostaglandins in the cerebrospinal fluid in cat, dog, and man. J. Neurochem. 43, 1642-1649.
39. Sakai K., Shimizu H., Koike T., Furuya S., and, Watanabe M., (2003) Neutral amino acid transporter ASCT1 is preferentially expressed in L-Ser-synthetic/storing glial cells in the mouse brain with transient expression in developing capillaries. J. Neurosci. 23, 550-560.
40. Scheld W. M., (1984) Rationale for optimal dosing of beta-lactam antibiotics in therapy for bacterial meningitis. Eur. J. Clin. Microbiol. 3, 579-591.
41. Schliamser S. E., Cars O., and, Norrby S. R., (1991) Neurotoxicity of beta-lactam antibiotics: predisposing factors and pathogenesis. J. Antimicrob. Chemother. 27, 405-425.
42. Sekine T., Watanabe N., Hosoyamada M., Kanai Y., and, Endou H., (1997) Expression cloning and characterization of a novel multispecific organic anion transporter. J. Biol. Chem. 272, 18526-18529.
43. Sekine T., Cha S. H., Tsuda M., Apiwattanakul N., Nakajima N., Kanai Y., and, Endou H., (1998) Identification of multispecific organic anion transporter 2 expressed predominantly in the liver. FEBS Lett. 429, 179-182.
44. Shiraya K., Hirata T., Hatano R., et al,. (2010) A novel transporter of SLC22 family specifically transports prostaglandins and co-localizes with 15-hydroxyprostaglandin dehydrogenase in renal proximal tubules. J. Biol. Chem. 285, 22141-22151.
45. Splawinski J. A., Gorka Z., Zacny E., and, Wojtaszek B., (1978) Hyperthermic effects of arachidonic acid, prostaglandin E2 and F2alpha in rats. Pflugers Arch. 374, 15-21.
46. Sunden Y., Park C. H., Matsuda K., Anagawa A., Kimura T., Ochiai K., Kida H., and, Umemura T., (2003) The effects of antipyretics on influenza virus encephalitis in mice and chicks. J. Vet. Med. Sci. 65, 1185-1188.
47. Suzuki H., Sawada Y., Sugiyama Y., Iga T., and, Hanano M., (1985) Saturable transport of cimetidine from cerebrospinal fluid to blood in rats. J. Pharmacobiodyn. 8, 73-76.
48. Suzuki H., Sawada Y., Sugiyama Y., Iga T., and, Hanano M., (1987) Transport of benzylpenicillin by the rat choroid plexus in vitro. J. Pharmacol. Exp. Ther. 242, 660-665.
49. Sweet D. H., Miller D. S., Pritchard J. B., Fujiwara Y., Beier D. R., and, Nigam S. K., (2002) Impaired organic anion transport in kidney and choroid plexus of organic anion transporter 3 (Oat3 (Slc22a8)) knockout mice. J. Biol. Chem. 277, 26934-26943.
50. Tachikawa M., Fukaya M., Terasaki T., Ohtsuki S., and, Watanabe M., (2004) Distinct cellular expressions of creatine synthetic enzyme GAMT and creatine kinases uCK-Mi and CK-B suggest a novel neuron-glial relationship for brain energy homeostasis. Eur. J. Neurosci. 20, 144-160.
51. Tachikawa M., Fujinawa J., Takahashi M., et al,. (2008a) Expression and possible role of creatine transporter in the brain and at the blood-cerebrospinal fluid barrier as a transporting protein of guanidinoacetate, an endogenous convulsant. J. Neurochem. 107, 768-778.
52. Tachikawa M., Kasai Y., Takahashi M., Fujinawa J., Kitaichi K., Terasaki T., and, Hosoya K., (2008b) The blood-cerebrospinal fluid barrier is a major pathway of cerebral creatinine clearance: involvement of transporter-mediated process. J. Neurochem. 107, 432-442.
53. 2, a sleep-promoting factor, in the cerebrospinal fluid: role of the blood-cerebrospinal barrier transporters. J. Pharmacol. Exp. Ther. doi: 10.1124/jpet.112.197012. (in press).
54. Takeda M., Babu E., Narikawa S., and, Endou H., (2002) Interaction of human organic anion transporters with various cephalosporin antibiotics. Eur. J. Pharmacol. 438, 137-142.
55. Vazquez-Tello A., Fan L., Hou X., Joyal J. S., Mancini J. A., Quiniou C., Clyman R. I., Gobeil Jr F., Varma D. R., and, Chemtob S., (2004) Intracellular-specific colocalization of prostaglandin E2 synthases and cyclooxygenases in the brain. Am. J. Physiol. Regul. Integr. Comp. Physiol. 287, R1155-R1163.
56. de Waart D. R., Paulusma C. C., Kunne C., and, Oude Elferink R. P., (2006) Multidrug resistance associated protein 2 mediates transport of prostaglandin E2. Liver Int. 26, 362-368.
57. Walters H. C., Craddock A. L., Fusegawa H., Willingham M. C., and, Dawson P. A., (2000) Expression, transport properties, and chromosomal location of organic anion transporter subtype 3. Am. J. Physiol. Gastrointest. Liver Physiol. 279, G1188-G1200.
58. Wijnholds J., deLange E. C., Scheffer G. L., van den Berg D. J., Mol C. A., van d. V. M., Schinkel A. H., Scheper R. J., Breimer D. D., and, Borst P., (2000) Multidrug resistance protein 1 protects the choroid plexus epithelium and contributes to the blood-cerebrospinal fluid barrier. J. Clin. Invest. 105, 279-285.
59. Yamagata K., Matsumura K., Inoue W., Shiraki T., Suzuki K., Yasuda S., Sugiura H., Cao C., Watanabe Y., and, Kobayashi S., (2001) Coexpression of microsomal-type prostaglandin E synthase with cyclooxygenase-2 in brain endothelial cells of rats during endotoxin-induced fever. J. Neurosci. 21, 2669-2677.
60. Yamaoka K., Tanaka H., Okumura K., Yasuhara M., and, Hori R., (1986) An analysis program MULTI(ELS) based on extended nonlinear least squares method for microcomputers. J. Pharmacobiodyn. 9, 161-173.